Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Bristol Myers Squibb

02 2Celgene Corporation

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Luspatercept

Brand Name : Reblozyl

Dosage Form : Powder For Solution For Injection

Dosage Strength : 25mg

Packaging :

Approval Date : 25/06/2020

Application Number : 20190430000030

Regulatory Info : Approved

Registration Country : Sweden

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Luspatercept

Brand Name : Reblozyl

Dosage Form : Powder For Solution For Injection

Dosage Strength : 75mg

Packaging :

Approval Date : 25/06/2020

Application Number : 20190430000047

Regulatory Info : Approved

Registration Country : Sweden

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

LUSPATERCEPT

Brand Name : REBLOZYL

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 25MG/VIAL

Packaging :

Approval Date :

Application Number : 2505541

Regulatory Info : Schedule D

Registration Country : Canada

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

LUSPATERCEPT

Brand Name : REBLOZYL

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 75MG/VIAL

Packaging :

Approval Date :

Application Number : 2505568

Regulatory Info : Schedule D

Registration Country : Canada

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Luspatercept

Brand Name : Reblozyl

Dosage Form : Powder For Injectable Solution

Dosage Strength : 75MG

Packaging :

Approval Date : 2020-08-18

Application Number : 1201452002

Regulatory Info : Authorized

Registration Country : Spain

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Luspatercept

Brand Name : Reblozyl

Dosage Form : Powder For Injectable Solution

Dosage Strength : 25MG

Packaging :

Approval Date : 2020-08-18

Application Number : 1201452001

Regulatory Info : Authorized

Registration Country : Spain

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

LUSPATERCEPT-AAMT

Brand Name : REBLOZYL

Dosage Form : POWDER;SUBCUTANEOUS

Dosage Strength : 25MG/VIAL

Packaging :

Approval Date :

Application Number : 761136

Regulatory Info :

Registration Country : USA

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

LUSPATERCEPT-AAMT

Brand Name : REBLOZYL

Dosage Form : POWDER;SUBCUTANEOUS

Dosage Strength : 75MG/VIAL

Packaging :

Approval Date :

Application Number : 761136

Regulatory Info :

Registration Country : USA

blank